SharesGrow.com S&P・Nasdaq 本質的価値お問い合わせ

हिन्दी

← 全銘柄に戻る

Exelixis, Inc. EXEL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Analyst Price Target

Exelixis, Inc. (EXEL) には 12 社の同業他社が比較対象として特定されています Healthcare セクター. 同業他社には ALNY, BMRN, BTAI, HALO, ICPT, KOD など.

EXEL の時価総額は $12.3B, 同業他社の平均時価総額と比較して $8.63B.

同業・類似企業 — EXEL

Alnylam Pharmaceuticals, Inc.

$339.41 +1.92% $45.01B

BioMarin Pharmaceutical Inc.

$55.47 +1.08% $10.67B

BioXcel Therapeutics, Inc.

$1.06 +3.92% $28.7M

Halozyme Therapeutics, Inc.

$67.31 +0.49% $7.97B

Intercept Pharmaceuticals, Inc.

$19.00 +0.21% $794.69M

Kodiak Sciences Inc.

$45.07 +7.44% $2.39B

Krystal Biotech, Inc.

$270.00 +0.97% $7.89B

Madrigal Pharmaceuticals, Inc.

$524.99 -0.13% $12.04B

Mirati Therapeutics, Inc.

$58.70 -0.17% $4.12B

PDS Biotechnology Corporation

$1.06 -2.75% $59.16M

PTC Therapeutics, Inc.

$73.01 +3.68% $6.04B

Reata Pharmaceuticals, Inc.

$172.36 +0.02% $6.57B

他のユーザーも閲覧

Alnylam Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.

BioMarin Pharmaceutical Inc.

Halozyme Therapeutics, Inc.

Krystal Biotech, Inc.

Reata Pharmaceuticals, Inc.

PTC Therapeutics, Inc.

お問い合わせ

🎓

SharesGrow アカデミー

本質的価値の計算と割安株の見つけ方を学ぶ。

毎週のライブセッション

📧 [email protected]

📞 +65 8912 8000

メッセージを送る